How I treat sickle cell disease with hematopoietic cell transplantation-Reference-Cited by-同舟云学术

How I treat sickle cell disease with hematopoietic cell transplantation

Published:2019-12-19 Issue:25 Volume:134 Page:2249-2260
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Stenger Elizabeth O.¹,Shenoy Shalini²,Krishnamurti Lakshmanan³^ORCID

Affiliation:

1. Division of Blood and Marrow Transplantation and Cellular Therapies, UPMC Children’s Hospital of Pittsburgh, Pittsburgh, PA;

2. Division of Hematology/Oncology, Children’s Hospital St. Louis, St. Louis, MO; and

3. Aflac Cancer and Blood Disorders Center, Children’s Healthcare of Atlanta, Atlanta, GA

Abstract

Hematopoietic stem cell transplantation can be curative for sickle cell disease, but decision-making is often complex. This How I Treat provides a perspective on how to negotiate this process for an individual patient.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/134/25/2249/1549269/bloodbld2019000821c.pdf

Reference99 articles.

1. Bone marrow transplantation for sickle cell disease;Walters;N Engl J Med,1996

2. Successful matched sibling donor marrow transplantation following reduced intensity conditioning in children with hemoglobinopathies;King;Am J Hematol,2015

3. Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease;Bernaudin;Blood,2007

4. Sickle cell disease: an international survey of results of HLA-identical sibling hematopoietic stem cell transplantation;Gluckman;Blood,2017

5. Bone marrow transplantation for adolescents and young adults with sickle cell disease: Results of a prospective multicenter pilot study;Krishnamurti;Am J Hematol,2019

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Long‐term quality of life after hematopoietic cell transplant for sickle cell disease in childhood: A STELLAR interim analysis;American Journal of Hematology;2024-08-06

2. CRISPR technology in human diseases;MedComm;2024-07-29

3. Advances in pharmacotherapy for sickle cell disease: what is the current state of play?;Expert Opinion on Pharmacotherapy;2024-07-02

4. Haploidentical allogeneic stem cell transplantation with post-transplant cyclophosphamide and subsequent kidney transplant for patients with severe sickle cell disease with end-stage kidney disease (ESKD);Bone Marrow Transplantation;2023-04-12

5. Stem Cell Transplant for Hemoglobinopathies;Basics of Hematopoietic Stem Cell Transplant;2023